81MO Osimertinib as neoadjuvant therapy in patients with EGFR mutated resectable stage II-IIIB lung adenocarcinoma (NEOS): Updated results C. Lyu, W. Fang, W. Jiao, H. Ma, J. Wang, S. Xu, N. Wu, R. Wang,Y. YangAnnals of Oncology（2022）引用 9|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
